Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies
Fabio Morandi, Irma Airoldi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 2925-2925
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

The Significance of SPP1 in Lung Cancers and Its Impact as a Marker for Protumor Tumor-Associated Macrophages
Eri Matsubara, Hiromu Yano, Cheng Pan, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2250-2250
Open Access | Times Cited: 59
Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance
Xiaoting Zhou, Yanghong Ni, Xiao Liang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 51
The potential applications of peptide-loading complex in cancer treatment
Zhidu Song, Ying Tao, Jiaxin You
Frontiers in Immunology (2025) Vol. 16
Open Access
Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps
Yanhua Zuo, Guangyi Leng, Ping Leng
Pathology & Oncology Research (2023) Vol. 29
Open Access | Times Cited: 11
Development of a novel hypoxia-immune–related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer
Likun Luan, Youguo Dai, Tao Shen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Implications of single-cell immune landscape of tumor microenvironment for the colorectal cancer diagnostics and therapy
Ahmad Alzamami
Medical Oncology (2023) Vol. 40, Iss. 12
Closed Access | Times Cited: 9
Strategies for Overcoming Immune Evasion in Bladder Cancer
Juhyun Shin, Jeong Youp Park, Seon Wook Kim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3105-3105
Open Access | Times Cited: 3
Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors
Ravit Geva, María Vieito, Jorge Ramón, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 10
Open Access | Times Cited: 3
Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients
Vladimı́ra Ďurmanová, Miroslav Tedla, Dusan Rada, et al.
Diseases (2024) Vol. 12, Iss. 2, pp. 34-34
Open Access | Times Cited: 2
Global trends in research of immune cells associated with hypertensive disorders of pregnancy: A 20-year bibliometric analyses (from 2001 to 2021)
Yue Wang, Baoxuan Li, Fei Tong
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 6
Relationships Between Polymorphisms in HLA-G 3’UTR Region and COVID-19 Disease Severity
Ahmed Alyami, Fawziya Barnawi, S E Christmas, et al.
Biochemical Genetics (2024)
Closed Access | Times Cited: 1
Targeting of Non-Classical Human Leukocyte Antigens as Novel Therapeutic Strategies in Cancer
Javier David Benítez Fuentes, Jorge Bartolomé, Kauzar Mohamed Mohamed, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4266-4266
Open Access | Times Cited: 1
IDO-1 impairs antitumor immunity of natural killer cells in triple-negative breast cancer via up-regulation of HLA-G
Rui Jing, Shukun Bai, Peipei Zhang, et al.
Breast Cancer (2023) Vol. 31, Iss. 1, pp. 135-147
Open Access | Times Cited: 4
The Potential Role of HLA-G on Solid Cancers
Figen Abatay Sel, Fatma Savran Oğuz
Interdisciplinary cancer research (2024)
Closed Access | Times Cited: 1
Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor
Steven M. Blum, Daniel A. Zlotoff, Neal P. Smith, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Association of HLA-G 3′UTR Polymorphisms with Response to First-Line FOLFIRI Treatment in Metastatic Colorectal Cancer
Lucia Scarabel, Jerry Polesel, Elena De Mattia, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2737-2737
Open Access | Times Cited: 5
Extracellular Vesicles—A New Potential Player in the Immunology of Renal Cell Carcinoma
Marcin Kleibert, Miłosz Majka, Klaudia Łakomska, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 772-772
Open Access | Times Cited: 4
INPP5A/HLA-G1/IL-10/MMP-21 Axis in Progression of Esophageal Squamous Cell Carcinoma
Sima Ardalan Khales, Azadeh Aarabi, Mohammad Reza Abbaszadegan, et al.
Iranian Biomedical Journal (2022) Vol. 26, Iss. 6, pp. 440-453
Open Access | Times Cited: 4
Non-Classical HLA Class 1b and Hepatocellular Carcinoma
Vallì De Re, Maria Lina Tornesello, Vito Racanelli, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1672-1672
Open Access | Times Cited: 2
Prognostic significance of HLA-G in patients with colorectal cancer: a meta-analysis and bioinformatics analysis
Yingying Zhang, Siying He, Lisha Yu, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Can senolysis be used to overcome tumor immune evasion?
Wally Veklych, Thomas E. Ichim, Robert Reznik, et al.
Journal of Stem Cell Research & Therapeutics (2024) Vol. 9, Iss. 1, pp. 26-32
Open Access
Ralationship between polymorphisms and diplotypes of HLA-G 3’UTR and fetuses with abnormal chromosomes or unexplained pregnancy loss (UPL)
Dan‐Ping Xu, Yiyang Zhu, Jun Wang, et al.
Human Genomics (2024) Vol. 18, Iss. 1
Open Access
Natural killer cell-based therapies in neuroblastoma
Abtin Ghasempour, Rashin Mohseni, Pouya Mahdavi Sharif, et al.
Cellular Immunology (2024) Vol. 407, pp. 104898-104898
Closed Access
FloraStilbene: immunotherapy adjuvant for breast cancer
Famela Ramos, Santosh Kesari, George Delgado, et al.
Journal of Stem Cell Research & Therapeutics (2024) Vol. 9, Iss. 1, pp. 45-53
Open Access
Immune-regulatory properties carried by human amnion epithelial cells: Focus on the role of HLA-G and adenosinergic ectoenzymes
Fabio Morandi, Irma Airoldi, Andrea Faini, et al.
Human Immunology (2023) Vol. 84, Iss. 8, pp. 359-365
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top